A case series of dual biologics therapy for severe asthma

被引:7
|
作者
Serajeddini, Hana [1 ,2 ]
Garrido, Carmen Venegas [1 ,2 ]
Bhalla, Anurag [3 ]
Kjarsgaard, Melanie [1 ,2 ]
Huang, Chynna [2 ]
LaVigne, Nicola [2 ]
Radford, Katherine [2 ]
Zhang, Kayla [2 ]
Ho, Terence [1 ,2 ]
Svenningsen, Sarah [1 ,2 ]
Mukherjee, Manali [1 ,2 ]
Nair, Parameswaran [1 ,2 ]
机构
[1] St Josephs Healthcare Hamilton, Firestone Inst Resp Hlth, Res Inst St Joes, Hamilton, ON, Canada
[2] McMaster Univ, Div Respirol, Dept Med, Hamilton, ON, Canada
[3] Western Univ, Div Respirol, Dept Med, London, ON, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1016/j.jaip.2022.09.036
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:335 / +
页数:8
相关论文
共 50 条
  • [31] Dual Monoclonal Antibody Therapy for a Severe Asthma Patient
    Domingo, Christian
    Pomares, Xavier
    Moron, Anisi
    Sogo, Ana
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [32] Do older patients with severe asthma respond to asthma biologics?
    Soe, Wint Wah
    Mittal, Rahul
    Cook, Peter
    Eames, Chellan
    Kerley, Sumita
    Whitfield, Ciara
    Pantaleon, Ma
    McCreery, Jodi
    Freeman, Anna
    Haitchi, Hans Michael
    Kurukulaaratchy, Ramesh
    Dennison, Paddy
    Rupan, Hitasha
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [33] Criteria for Evaluating Response to Biologics in severe Asthma- the Biologics Asthma Response Score (BARS)
    Milger-Kneidinger, K.
    Korn, S.
    Feder, C.
    Fuge, J.
    Muhle, A.
    Schutte, W.
    Skowasch, D.
    Timmermann, H.
    Suhling, H.
    PNEUMOLOGIE, 2023, 77 : S108 - S108
  • [34] Efficacy of biologics for severe asthma on allergic comorbidities
    de Menonville, C. Thibaut
    Barakat, L.
    Laborier, F.
    Le Brun, M.
    Dupin, C.
    Neukirch, C.
    Taille, C.
    REVUE DES MALADIES RESPIRATOIRES, 2024, 41 (09) : 669 - 679
  • [35] Severe asthma and eligibility for biologics in a Brazilian cohort
    Marques Mello, Luane
    Viana, Karynna P.
    Moraes dos Santos, Felipe
    Saturnino, Luciana T. M.
    Kormann, Michelle L.
    Lazaridis, Evelyn
    Torreao, Cinthia D.
    Soares, Claudia R.
    Abreu, Gabriela A.
    de Lima, Valmar Biao
    Pinheiro, Gabriela P.
    Lima-Matos, Aline
    Ponte, Eduardo Vieira
    Mohan, Divya
    Riley, John H.
    Cruz, Alvaro A.
    JOURNAL OF ASTHMA, 2021, 58 (07) : 958 - 966
  • [36] Biologics for the Treatments of Allergic Conditions Severe Asthma
    Caminati, Marco
    Bagnasco, Diego
    Rosenwasser, Lanny J.
    Vianello, Andrea
    Senna, Gianenrico
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2020, 40 (04) : 549 - 564
  • [37] COVID-19, severe asthma, and biologics
    Garcia-Moguel, Ismael
    Campos, Rocio Diaz
    Charterina, Sergio Alonso
    Rodriguez, Consuelo Fernandez
    Crespo, Jesus Fernandez
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (03) : 357 - 359
  • [38] Frequency and reasons for biologics switching in severe asthma
    Gerstlauer, M.
    Seefeldt, M.
    Buhl, R.
    Hamelmann, E.
    Taube, C.
    Idzko, M.
    Korn, S.
    PNEUMOLOGIE, 2022, 76 : S31 - S31
  • [39] Selection of Biologics in Severe Asthma: A Multifaceted Algorithm
    Davila, I
    Quirce, S.
    Olaguibel, J. M.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (04) : 325 - 328
  • [40] EFFECTIVENESS OF OMALIZUMAB IN SEVERE ALLERGIC ASTHMA: CASE SERIES
    Yong, Kar Ying
    Ong, Andy Tang Sing
    Kim, Chan Siew
    Teck, Tie Siew
    RESPIROLOGY, 2015, 20 : 8 - 8